Tijana Skrepnik
Papers
1
Total Citations
4
H-Index
1
About
Tijana Skrepnik is a clinical researcher whose work bridges the critical intersection of oncology, immunotherapy, and radiosurgery. Her primary research focus lies in understanding how emerging immunotherapeutic agents interact with stereotactic radiosurgery in the treatment of brain metastases. Her most cited paper, "Does Immunotherapy Influence the Risk of Developing Radiation Necrosis After Radiosurgery of Brain Metastases?" (2017), directly addresses a pressing clinical question: whether combining these powerful therapies increases the risk of radiation necrosis, a debilitating complication. This work has garnered attention from the neuro-oncology community, accumulating 4 citations and contributing to the evolving safety profile of combination treatments. Skrepnik’s research is particularly valuable for clinicians and researchers navigating the complex balance between maximizing antitumor efficacy and minimizing treatment-related toxicity. By highlighting a previously underexplored risk, her study has helped shape clinical decision-making and future trial design. As the field of immuno-radiotherapy continues to expand, Skrepnik’s foundational insights remain relevant for those seeking to optimize outcomes for patients with metastatic brain disease.
Research Focus
Key Achievements
Top Papers
- 1